相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Assessment of the Acute Effects of 2C-B vs. Psilocybin on Subjective Experience, Mood, and Cognition
Pablo Mallaroni et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2023)
Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects
Anna M. Becker et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)
Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants
Felix Mueller et al.
PSYCHOPHARMACOLOGY (2022)
Defining Blood Plasma and Serum Metabolome by GC-MS
Olga Kiseleva et al.
METABOLITES (2022)
Metabolomics and integrated network analysis reveal roles of endocannabinoids and large neutral amino acid balance in the ayahuasca experience
Francisco Madrid-Gambin et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
Assessing the effects of methodological differences on outcomes in the use of psychedelics in the treatment of anxiety and depressive disorders: A systematic review and meta-analysis
Robert F. Leger et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2022)
Development and application of a highly sensitive LC-MS/MS method for simultaneous quantification of N,N-dimethyltryptamine and two of its metabolites in human plasma
Emma Eckernas et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2022)
Development and validation of an LC-MS/MS method for the quantification of mescaline and major metabolites in human plasma
Jan Thomann et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2022)
A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers
Johannes G. Ramaekers et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2021)
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Antonio Inserra et al.
PHARMACOLOGICAL REVIEWS (2021)
Development and validation of an LC-MS/MS method for the bioanalysis of psilocybin ' s main metabolites, psilocin and 4-hydroxyindole-3-acetic acid, in human plasma
Karolina E. Kolaczynska et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2021)
The Evolved Psychology of Psychedelic Set and Setting: Inferences Regarding the Roles of Shamanism and Entheogenic Ecopsychology
Michael James Winkelman
FRONTIERS IN PHARMACOLOGY (2021)
Persisting Effects of Ayahuasca on Empathy, Creative Thinking, Decentering, Personality, and Well-Being
Maggie K. Kiraga et al.
FRONTIERS IN PHARMACOLOGY (2021)
Further development of a liquid chromatography-high-resolution mass spectrometry/mass spectrometry-based strategy for analyzing eight biomarkers in human urine indicating toxic mushroom or Ricinus communis ingestions
Thomas P. Bambauer et al.
DRUG TESTING AND ANALYSIS (2021)
Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience
Martin K. Madsen et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2021)
Genetic influence of CYP2D6 on pharmacokinetics and acute subjective effects of LSD in a pooled analysis
Patrick Vizeli et al.
SCIENTIFIC REPORTS (2021)
Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics
Cato M. H. de Vos et al.
FRONTIERS IN PSYCHIATRY (2021)
Psychedelics and Psychedelic-Assisted Psychotherapy
Collin M. Reiff et al.
AMERICAN JOURNAL OF PSYCHIATRY (2020)
Prospective examination of synthetic 5-methoxy-N,N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment
Malin Uthaug et al.
PSYCHOPHARMACOLOGY (2020)
Long-term effects of psychedelic drugs: A systematic review
Jacob S. Aday et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2020)
Mood and cognition after administration of low LSD doses in healthy volunteers: A placebo controlled dose-effect finding study
Nadia R. P. W. Hutten et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)
Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders
Franz X. Vollenweider et al.
NATURE REVIEWS NEUROSCIENCE (2020)
Potential safety, benefits, and influence of the placebo effect in microdosing psychedelic drugs: A systematic review
Genis Ona et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2020)
Pharmacokinetics and subjective effects of a novel oral LSD formulation in healthy subjects
Friederike Holze et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels
Martin K. Madsen et al.
NEUROPSYCHOPHARMACOLOGY (2019)
Serotonin transporter-ibogaine complexes illuminate mechanisms of inhibition and transport
Jonathan A. Coleman et al.
NATURE (2019)
Chemical evidence for the use of multiple psychotropic plants in a 1,000-year-old ritual bundle from South America
Melanie J. Miller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms
M. V. Uthaug et al.
PSYCHOPHARMACOLOGY (2019)
Cytochrome P450 enzymes contribute to the metabolism of LSD to nor-LSD and 2-oxo-3-hydroxy-LSD: Implications for clinical LSD use
Dino Luethi et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Metabolism of lysergic acid diethylamide (LSD): an update
Rui Filipe Libanio Osorio Marta
DRUG METABOLISM REVIEWS (2019)
Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function
Matthew W. Johnson et al.
PHARMACOLOGY & THERAPEUTICS (2019)
The effects of microdose LSD on time perception: a randomised, double-blind, placebo-controlled trial
Steliana Yanakieva et al.
PSYCHOPHARMACOLOGY (2019)
Pharmacokinetic and Pharmacodynamic Aspects of Peyote and Mescaline: Clinical and Forensic Repercussions
Ricardo Jorge Dinis-Oliveira et al.
CURRENT MOLECULAR PHARMACOLOGY (2019)
Development and validation of an LC-MS/MS method to quantify lysergic acid diethylamide (LSD), iso-LSD, 2-oxo-3-hydroxy-LSD, and nor-LSD and identify novel metabolites in plasma samples in a controlled clinical trial
Patrick C. Dolder et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2018)
Dark Classics in Chemical Neuroscience: Lysergic Acid Diethylamide (LSD)
David E. Nichols
ACS CHEMICAL NEUROSCIENCE (2018)
Dark Classics in Chemical Neuroscience: N,N-Dimethyltryptamine (DMT)
Lindsay P. Cameron et al.
ACS CHEMICAL NEUROSCIENCE (2018)
Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution
M. V. Uthaug et al.
PSYCHOPHARMACOLOGY (2018)
A Metabolomics Approach to Pharmacotherapy Personalization
Elena E. Balashova et al.
JOURNAL OF PERSONALIZED MEDICINE (2018)
Development and validation of an ultra-fast and sensitive microflow liquid chromatography-tandem mass spectrometry (MFLC-MS/MS) method for quantification of LSD and its metabolites in plasma and application to a controlled LSD administration study in humans
Andrea E. Steuer et al.
DRUG TESTING AND ANALYSIS (2017)
First Time View on Human Metabolome Changes after a Single Intake of 3,4-Methylenedioxymethamphetamine in Healthy Placebo-Controlled Subjects
Martina I. Boxler et al.
JOURNAL OF PROTEOME RESEARCH (2017)
Modern Clinical Research on LSD
Matthias E. Liechti
NEUROPSYCHOPHARMACOLOGY (2017)
The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future
Robin L. Carhart-Harris et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults
Randall T. Brown et al.
CLINICAL PHARMACOKINETICS (2017)
Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance
Ricardo Jorge Dinis-Oliveira
DRUG METABOLISM REVIEWS (2017)
Pharmacokinetics and Concentration-Effect Relationship of Oral LSD in Humans
Patrick C. Dolder et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)
Sex differences and serotonergic mechanisms in the behavioural effects of psilocin
Filip Tyls et al.
BEHAVIOURAL PHARMACOLOGY (2016)
Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens
Anna Rickli et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)
Psychedelics in the treatment of unipolar mood disorders: a systematic review
James J. H. Rucker et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Metabolomics: beyond biomarkers and towards mechanisms
Caroline H. Johnson et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)
LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality
Patrick C. Dolder et al.
NEUROPSYCHOPHARMACOLOGY (2016)
Metabolomic signatures of drug response phenotypes for ketamine and esketamine in subjects with refractory major depressive disorder: new mechanistic insights for rapid acting antidepressants
D. M. Rotroff et al.
TRANSLATIONAL PSYCHIATRY (2016)
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years
Rafael G. dos Santos et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2016)
Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA
Michael C. Mithoefer et al.
LANCET PSYCHIATRY (2016)
Recent advances in the neuropsychopharmacology of serotonergic hallucinogens
Adam L. Halberstadt
BEHAVIOURAL BRAIN RESEARCH (2015)
Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers
Rainer Kraehenmann et al.
BIOLOGICAL PSYCHIATRY (2015)
Metabolism and urinary disposition of N,N-dimethyltryptamine after oral and smoked administration: a comparative study
Jordi Riba et al.
DRUG TESTING AND ANALYSIS (2015)
Standardizing the experimental conditions for using urine in NMR-based metabolomic studies with a particular focus on diagnostic studies: a review
Abdul-Hamid Emwas et al.
METABOLOMICS (2015)
The Psychedelic State Induced by Ayahuasca Modulates the Activity and Connectivity of the Default Mode Network
Fernanda Palhano-Fontes et al.
PLOS ONE (2015)
Therapeutic Effects of Ritual Ayahuasca Use in the Treatment of Substance Dependence-Qualitative Results
Anja Loizaga-Velder et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2014)
Metabolomics in Epidemiology: Sources of Variability in Metabolite Measurements and Implications
Joshua N. Sampson et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2013)
Determination of psilocin, bufotenine, LSD and its metabolites in serum, plasma and urine by SPE-LC-MS/MS
Rafaela Martin et al.
INTERNATIONAL JOURNAL OF LEGAL MEDICINE (2013)
Overlapping effects of genetic variation and epigenetics on drug response: challenges of pharmacoepigenomics
Ingolf Cascorbi
PHARMACOGENOMICS (2013)
Nutrimetabonomics: Applications for Nutritional Sciences, with Specific Reference to Gut Microbial Interactions
Sandrine P. Claus et al.
ANNUAL REVIEW OF FOOD SCIENCE AND TECHNOLOGY, VOL 4 (2013)
Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning
Briony J. Catlow et al.
EXPERIMENTAL BRAIN RESEARCH (2013)
Modern analytical techniques in metabolomics analysis
Aihua Zhang et al.
ANALYST (2012)
Psilocybin Biases Facial Recognition, Goal-Directed Behavior, and Mood State Toward Positive Relative to Negative Emotions Through Different Serotonergic Subreceptors
Michael Kometer et al.
BIOLOGICAL PSYCHIATRY (2012)
Methodology for determining major constituents of ayahuasca and their metabolites in blood
Ethan H. McIlhenny et al.
BIOMEDICAL CHROMATOGRAPHY (2012)
Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca
Jordi Riba et al.
DRUG TESTING AND ANALYSIS (2012)
The dynamic range of the human metabolome revealed by challenges
Susanne Krug et al.
FASEB JOURNAL (2012)
Methodology for and the determination of the major constituents and metabolites of the Amazonian botanical medicine ayahuasca in human urine
Ethan H. McIlhenny et al.
BIOMEDICAL CHROMATOGRAPHY (2011)
Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies
Erich Studerus et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens
Adam L. Halberstadt et al.
NEUROPHARMACOLOGY (2011)
Development and validation of a standardized protocol to monitor human dietary exposure by metabolite fingerprinting of urine samples
Gaelle Fave et al.
METABOLOMICS (2011)
Psychedelic 5-Methoxy-N,N-Dimethyltryptamine: Metabolism, Pharmacokinetics, Drug Interactions, and Pharmacological Actions
Hong-Wu Shen et al.
CURRENT DRUG METABOLISM (2010)
Glucuronidation of Psilocin and 4-Hydroxyindole by the Human UDP-Glucuronosyltransferases
Nenad Manevski et al.
DRUG METABOLISM AND DISPOSITION (2010)
Global metabolic profiling procedures for urine using UPLC-MS
Elizabeth J. Want et al.
NATURE PROTOCOLS (2010)
Metabolomics analysis I. Selection of biological samples and practical aspects preceding sample preparation
B. Alvarez-Sanchez et al.
TRAC-TRENDS IN ANALYTICAL CHEMISTRY (2010)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Indolealkylamines: Biotransformations and potential drug-drug interactions
Ai-Ming Yu
AAPS JOURNAL (2008)
Human hallucinogen research: guidelines for safety
M. W. Johnson et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Mescaline effects on rat behavior and its time profile in serum and brain tissue after a single subcutaneous dose
Tomas Palenicek et al.
PSYCHOPHARMACOLOGY (2008)
LC-ESI-MS/MS on an ion trap for the determination of LSD, iso-LSD, nor-LSD and 2-oxo-3-hydroxy-LSD in blood, urine and vitreous humor
Donata Favretto et al.
INTERNATIONAL JOURNAL OF LEGAL MEDICINE (2007)
Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts
Olaf Beckonert et al.
NATURE PROTOCOLS (2007)
Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder
Francisco A. Moreno et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
Increased frontal and paralimbic activation following ayahuasca, the pan-amazonian inebriant
J Riba et al.
PSYCHOPHARMACOLOGY (2006)
Metabolomics: Current analytical platforms and methodologies
WB Dunn et al.
TRAC-TRENDS IN ANALYTICAL CHEMISTRY (2005)
Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study
F Hasler et al.
PSYCHOPHARMACOLOGY (2004)
Optimized glucuronide hydrolysis for the detection of psilocin in human urine samples
T Kamata et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2003)
LC-MS analysis of 2-oxo-3-hydroxy LSD from urine using a Speedisk® positive-pressure processor with Cerex® PolyChrom™ CLIN II columns
CK Horn et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2003)
Human pharmacology of ayahuasca: Subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics
J Riba et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
The development and application of a gas chromatography-mass spectrometric (GC-MS) assay to determine the presence of 2-oxo-3-hydroxy-LSD in urine
BT Burnley et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2003)
Determination of N,N-dimethyltryptamine and β-carboline alkaloids in human plasma following oral administration of Ayahuasca
M Yritia et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2002)
The pharmacology of psilocybin
T Passie et al.
ADDICTION BIOLOGY (2002)
Renal excretion profiles of psilocin following oral administration of psilocybin: a controlled study in man
F Hasler et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2002)
LC-MS analysis of human urine specimens for 2-oxo-3-hydroxy LSD: Method validation for potential interferants, and stability study of 2-oxo-3-hydroxy LSD under various storage conditions
KL Klette et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2002)
Molecular genetics of CYP2D6:: Clinical relevance with focus on psychotropic drugs
L Bertilsson et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Metabolomics - the link between genotypes and phenotypes
O Fiehn
PLANT MOLECULAR BIOLOGY (2002)
Bufotenine: Toward an understanding of possible psychoactive mechanisms
MC McBride
JOURNAL OF PSYCHOACTIVE DRUGS (2000)
Direct plasma sample injection in multiple-component LC-MS-MS assays for high-throughput pharmacokinetic screening
JT Wu et al.
ANALYTICAL CHEMISTRY (2000)
分享论文
